Campbell Alliance Announces Expanded Pricing Services for Pharmaceutical and Biotech Clients

September 25, 2006



Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotechnology industries, today announced expanded capabilities in the area of pricing for pharmaceutical and biotech clients.


“Over the years, we have built extensive experience in pricing-related work.  We haven’t actively sought that business, simply because our clients have repeatedly reached out to us, asking for help in developing pricing and contracting strategies.  Now, however, we are announcing and promoting a formalized service offering,” stated John Campbell, CEO of Campbell Alliance.


“In our experience, companies are beginning to build pricing strategies much earlier in product development, and they are taking much more of a cross-functional approach, involving professionals in new product planning, marketing, access and reimbursement, contracting, and so on.  Our Managed Markets and Brand Management practices combine expertise in all of those functions and have in-depth understanding of key therapeutic areas, including oncology, CNS, GI, and cardiovascular.  It’s that combination that sets us apart from other firms providing services in this space,” added Campbell.


Campbell Alliance has developed sophisticated research, modeling, and scenario planning techniques to estimate the impact of price on market access, reimbursement, and utilization, as well as to develop detailed payer contracting strategies.  The firm has extensive pricing experience at the product and portfolio levels, including helping clients determine the optimum list price and net price for new products, as well as develop pricing strategies for in-line products with new indications.  


“Our true differentiator from competing firms is our ability to optimize the pricing equation across the payer, physician, and patient channels, including how pricing and formulary access affect key decisions,” said Kevin Barnett, Senior Vice President and leader of the firm’s Managed Markets Practice.



About Campbell Alliance


Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industries.  The firm's clients include most of the world's "top 20" pharmaceutical companies, as well as numerous emerging and midsize firms.  Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, and Sales.  From its locations in Raleigh, N.C., Parsippany, N.J., Los Angeles, South San Francisco, Calif., Chicago, Boston, and New York City, the firm serves clients throughout North America, Europe, and Japan.  For more information on Campbell Alliance, please visit


inVentiv Health Consulting offers world class healthcare consulting services.

Media Contact:

Stephanie Koenig